Magle Chemoswed
Inhalation
Solid State
CDMO
Analytical development
Process development
Crystallization
Manufacturing
Freeze drying
Fill and Finish
Quality
Technology
Products
Investors
Award
About us
Our story
How we work
Contact us
Meny
Magle Group’s vascular embolic product Embocept® S receives regulatory approval in Argentina
Magle Chemoswed Holding AB announces change of Certified Adviser to Vator Securities
First patients enrolled in a post-market study of Magle Group’s innovative medical device SmartPAN®
Magle Group announces innovation sponsorship with leading life science incubator in Sweden
Magle Group announces post market clinical study for SmartPAN®
Magle Group signs pre-agreement to acquire land in Malmö
EmboCept®S included in the European treatment guidelines
Magle Chemoswed establishes a manufacturing agreement with Oncopeptides
Magle Chemoswed announces confirmation of manufacturing order for delivery in 2022.
Magle Chemoswed Holding (publ) today announced that it has filed a patent application that will be used in the ongoing SmartBONE project in the field of bone tissue engineering.